Cancer Pain Management
Assess cancer-related pain, select and titrate opioids, and manage breakthrough pain and adjuvant therapies with more confidence.
What this track covers
This track covers pain assessment in cancer patients, including validated scales and recognition of distinct pain syndromes and mechanisms. It works through opioid selection, dose titration, equianalgesic conversion, breakthrough pain management, non-opioid adjuvants, and when interventional or palliative referral is appropriate.
What you will practice
- Score and document pain using a validated assessment scale
- Distinguish nociceptive, neuropathic, and mixed cancer pain syndromes
- Reason through opioid selection based on patient-specific factors
- Work through equianalgesic conversion and dose titration logic
- Decide when adjuvant therapy or interventional referral is indicated
Simulator scenario
A hospitalized patient with metastatic disease and escalating pain despite a stable opioid regimen, requiring reassessment, possible rotation, and a breakthrough pain plan.
Board question topics
- Equianalgesic dose conversion
- Recognizing opioid-induced adverse effects
- Adjuvant selection for neuropathic cancer pain
- Indications for interventional pain referral
Ask the tutor
The tutor only answers from licensed sources (FDA prescribing information, public guidelines and our own material) and says when it has none. Educational use only, never patient-specific advice.
Free during the beta. Sign in with your email, no password.
Start free